A Case to Support the Continued Use of Rifampin in Clinical Drug-Drug Interaction Studies

Clin Pharmacol Ther. 2024 Mar 18. doi: 10.1002/cpt.3256. Online ahead of print.NO ABSTRACTPMID:38494918 | DOI:10.1002/cpt.3256
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Source Type: research